Costliest Drugs in England — NHS Prescribing Data — Page 4
Page 4 of 89
| # | Drug | Category | NHS Cost | Items |
|---|---|---|---|---|
| 91 | Buprenorphine hydrochloride | Central Nervous System | £24.1M | 872.1K |
| 92 | Insulin Lispro | Endocrine System | £24.1M | 492.5K |
| 93 | Biphasic isophane insulin | Endocrine System | £23.8M | 697.3K |
| 94 | Methotrexate | Musculoskeletal and Joint Diseases | £23.5M | 2.1M |
| 95 | Estradiol | Obstetrics, Gynaecology and Urinary-Tract Disorders | £22.9M | 1.8M |
| 96 | Ready to serve 1.5 kcal/ml juice style (0913011) | Nutrition and Blood | £22.9M | 393.6K |
| 97 | Rifaximin | Infections | £22.2M | 125.2K |
| 98 | Bisoprolol fumarate | Cardiovascular System | £22.0M | 30.1M |
| 99 | Sulfasalazine | Gastro-Intestinal System | £21.8M | 827.4K |
| 100 | Somatropin | Endocrine System | £21.3M | 38.1K |
| 101 | Estriol | Obstetrics, Gynaecology and Urinary-Tract Disorders | £21.0M | 1.5M |
| 102 | Hydrocortisone | Skin | £20.8M | 3.5M |
| 103 | Felodipine | Cardiovascular System | £20.8M | 4.0M |
| 104 | Propranolol hydrochloride | Cardiovascular System | £20.4M | 8.0M |
| 105 | Denosumab | Endocrine System | £20.2M | 109.8K |
| 106 | Diclofenac diethyl | Musculoskeletal and Joint Diseases | £19.8M | 2.5M |
| 107 | Isosorbide mononitrate | Cardiovascular System | £19.6M | 4.5M |
| 108 | Latanoprost | Eye | £19.5M | 3.3M |
| 109 | Bempedoic acid/Ezetimibe | Cardiovascular System | £19.2M | 323.2K |
| 110 | Naproxen | Musculoskeletal and Joint Diseases | £18.9M | 7.6M |
| 111 | Isophane insulin | Endocrine System | £18.8M | 693.3K |
| 112 | Tramadol hydrochloride | Central Nervous System | £18.7M | 5.2M |
| 113 | Testosterone | Endocrine System | £18.7M | 486.8K |
| 114 | Appliances | £18.1M | 3.3M | |
| 115 | Brivaracetam | Central Nervous System | £17.9M | 147.6K |
| 116 | Lidocaine hydrochloride | Anaesthesia | £17.8M | 1.3M |
| 117 | Rotigotine | Central Nervous System | £17.3M | 132.5K |
| 118 | Docusate sodium | Gastro-Intestinal System | £17.3M | 2.7M |
| 119 | Colesevelam hydrochloride | Cardiovascular System | £17.0M | 224.5K |
| 120 | Triptorelin | Malignant Disease and Immunosuppression | £16.9M | 85.0K |